Objectives: The epigallocatechin-3-gallate (EGCg) that is present in human diet originates mainly from tea leaves. Catechins have a number of possible application as medicines, however, there is no consistent evidence showing their influence on the gastrointestinal tract. Thus, the aim of the present study was to investigate the effect of EGCg on the motility of the murine isolated intestine.
transit in the small intestine (4) . Another study concerning the effects of polyphenolic compounds on gastrointestinal transit has shown that kampferol morin, myricetin, and rutin have a strong, dose-dependent inhibitory effect on charcoal transit in mice. Catechin, however, did not show a significant effect (5) . An in vitro study has shown that EGCg has direct depolarizing effects on a population of myenteric neurons in the guinea-pig small intestine (6) . Moreover, EGCg facilitates cholinergic ganglion transmission in enteric neurons (7) .
Since catechins are compounds of potential use as medicines, there is a need to investigate their effects on various organs. Based on available evidence it is unclear if catechins are potent factors influencing gastrointestinal motility. In addition, there is no study reporting the effects and mechanisms of catechins on the functional activity of the intestine in vitro. Thus, the aim of the present study was to characterize the effects and mechanisms of action of EGCg on mechanical activity of the mouse small intestine.
Methods

Animals
Female, ddy mice (31.7±6.7 g) were used in all experi-ments. The animals had free access to laboratory chow and tap water before the experiment and were kept under artificial lighting 12 hours per day at 20°C to 22°C. Experimental protocols were carried out according to the principles and guidelines of the National Institute for Physiological Sciences in Japan.
In vitro intestinal motility recording
The animals were anesthetized with ether and then stomach and intestinal tissues were harvested. Segments of proximal jejunum (approximately 7 mm long) were prepared and mounted in a 10-ml organ bath. The organ bath contained Krebs solution with the following composition (in mM): NaCl 118, KCl 4.8, KH 2 PO 4 1.2, MgSO 4 1.2, CaCl 2 1.9, NaHCO 3 25, and glucose 10.1. The Krebs solution was constantly gassed with a 95% O 2 , 5% CO 2 mixture. The temperature of the buffer was maintained at 37°C. Changes in the tension of the strips were recorded isometrically with force transducers (type 45196A, NEC San-ei Instruments Ltd., Japan) coupled with a PowerLab recording system (ADInstruments, Australia).
The mechanical activity of jejunal segments was recorded in accordance with the following schedule. The strips were allowed to equilibrate for 30 minutes. Next, acetylcholine (ACh, 10 −6 M) was added to the bath. Next EGCg was added to the chamber in a noncumulative manner in concentrations 10 
, 10
−4 , and 10 −3 M (Fig. 1) . For the quantitative analysis, the following concentrations were used 3.7V10 , and 1V10 −3 M. The response to each administration of catechins was recorded for 10 minutes. Then the chamber was washed out for the next 10 minutes, followed by the administration of EGCg. At the end of the experiment, another ACh trial was performed in the same manner as at the beginning of the experiment.
Mechanism of catechin action
After equilibration, EGCg was added in a concentration of 5V10 −4 M. Next, compounds of known pharmacological action were added to the chamber, and in their presence the segments were again exposed to EGCg. The following compounds were used: 10 −6 M tetrodotoxin (TTX, sodium channel blocker), 10 −4 M methylene blue (MB, guanylate cyclase inhibitor), 10 −4 M L-nitro arginine methyl ester (L-NAME, nitric oxide synthase inhibitor), and 10 −5 M N-ethylmaleimide (NEM, adenylate cyclase inhibitor).
Chemicals
EGCg was a gift from Tokyo Food Techno Co. LTD. (Tokyo, Japan). The substance was −(−) EGCg isomer. The purity of the compound was 98.4%. EGCg was isolated from green tea leaves using the modified method presented by Hara et al. (8) . EGCg was isolated from green tea leaves using the following extraction: first, hot water extract, then organic solvent extract (ethyl acetate). The next step was a crude isolation using synthetic resin (Sepabeds, Mitsubishi Chemical Company, Japan) followed by an isolation using ODS (Siliciferous with octa decyl silyl). Finally, EGCg was crystallized from methanolwater solution. The rest of the compounds were purchased from Sigma (St. Louis, USA).
Statistics
All values are expressed as means±SEM. Results from control-and EGCg-treated tissues were compared by ANOVA and Tukey post hoc test. A p value<0.05 was considered to be statistically significant.
Results
The effect of catechins on spontaneous contractions
EGCg induced a decrease in the spontaneous activity of the jejunum. The effect was observed as a decrease in the frequency and amplitude of contractions ( Fig. 1, 2 , and 3). The decrease in amplitude induced by EGCg was dose-dependent, while the highest concentration EGCg induced a significant increase in the frequency of contractions (Fig. 3) . In the presence of EGCg, the rythmicity of spontaneous contractions was markedly altered (Fig. 2) . The effect of EGCg 3.3×10 −4 M lasted approximately 20 minutes. It was necessary to change the buffer twice to restore the spontaneous contractility close to the initial level.
Acetylcholine-induced contractions
ACh was used as a control for the contractility of the intestine at the beginning and the end of the experiment. The addition of 10 −6 M of ACh induced a single, strong contraction that lasted approximately 30 seconds. Then the activity of the intestine returned to the control value. There were no significant differences between the control contraction at the beginning of the experiment and that induced at the end (Fig. 4) .
The mechanism of catechin action
In the present study TTX, 10 −6 M, NEM, 10 −5 M, and L-NAME, 10 −4 M did not significantly affect the spontaneous activity of the isolated intestine. Moreover, they had no significant effects on an EGCg-induced decrease in spontaneous jejunal activity, both in terms of the frequency and amplitude of the contractions. On the other hand, guanylate cyclase inhibitor MB 10 −4 M (which also showed no significant influence on spontaneous motility) effectively influenced the EGCginduced decrease in the amplitude of jejunal motility. However, MB did not completely reverse the EGCg-induced inhibition of spontaneous motility. Moreover, MB showed no significant influence on the frequency of contractions. (Figs. 5 and 6 ). 
Conclusions
EGCg performs a variety of biological activities, including antitumor as well as antimicrobial activity against some pathogens. There is evidence suggesting that the treatment of mouse skin with EGCg prevents UV-B-induced leukocyte infiltration, antigen-presenting cell infiltration, and oxidative stress. In this way EGCg may evoke the prevention of UV-B-induced immunosuppression and photocarcinogenesis (9) . Moreover, pretreatment with EGCg restores the UV-induced decrease in the total glutathione level and affords protection to the antioxidant enzyme glutathione peroxidase (9) . EGCg shows the strongest activity of the six tea catechins tested against Helicobacter pylori (10). EGCg selectively up-regulates the production of IL-12 and tumor necrosis factor alpha, and down-regulates IL-10 production in macrophages induced by Legionella pneumophila infection (11) .
Catechins influence gastrointestinal functions other than motility. Meciadanol (O-methyl-3(+)-catechin), a synthetic flavonoid, protects against ulcerogens and does not affect either gastric acid secretion or pepsin output in rats (12, 13) . On the other hand, catechins inhibit gastric H+, K(+)-ATPase activity, and EGCg is the most potent inhibitor. The intensity of inhibitor activity parallels the number of phenolic hydroxy groups in the molecule. These findings suggest that the anti-secretory and anti-ulcerogenic effects of catechins are due to their inhibitory activity on gastric H+, K(+)-ATPase (14) .
The findings of the present study showed that EGCg derived from tea leaves can alter spontaneous activity of the small intestine. However, the effect appears at relatively high concentrations. The level of availability of catechins has been confirmed at lower concentrations (15, 3) . The plasma concentrations and doses presented in recent studies were much lower than that presented as effective in the present study. The lowest concentration that was effective in the present study was 10 −4 M of EGCg. It was reported that in brews the extraction efficiency of catechins is approximately 50% (16) . Based on the catechin content in tea leaves, it can be calculated that the concentration of EGCg in a brew is 74.5 mg/100 ml, which gives a molar concentration 1.65 10 −3 M. Thus, it is possible that tea drinking can influence intestinal motility. On the other hand, the proposed antioxidative action that has been reported at the concentrations in the range of 10 −6 M (2, 17) may be reached without a disturbance of gastrointestinal motility. However, the potential inhibitory influence of catechins on intestinal motility is possible in the case of longer exposures or higher concentrations.
The present study shows that the frequency of contractions in the presence of the highest concentration of EGCg increased, while the amplitude was significantly smaller than that of the control. Such an effect was a result of the presence of a large number of small irregular contractions. This activity was still higher than the noise that was visible in the presence of papaverine 10 −3 M. In the presence of papaverine, the amplitude and frequency was completely abolished (data not shown). Thus, one can conclude that the activity observed in the presence of EGCg was the actvity of intestinal smooth muscle. Moreover, the numbe of small contractions suggests that in the presence of EGCg the integrated activity of the intestinal segment is markedly disrupted. Smooth muscle in the intestine works as an integrated mechanism. Contractions are evoked by changes in the membrane potential, called slow waves, that originate from pacemaker regions located at the myenteric and submucosal borders of circular muscle (18) . The slow waves propagate rapidly in the muscle. Slow wave transmition is facilitated by the peripheral network of intersitial cells, the abundance of gap junctions, and the neuronal network of the enteric nervous system. It leads to organized contractions in the whole segmnent of the intestine. Thus, the decrease in amplitude with an increase in frequency suggests that EGCg disrupts the organized contractions in the intestinal segments.
The present study shows that EGCg induces a significant disruption of spontaneous activity in the small intestine. The mechanism of this action most likely involves direct cellular action since TTX and L-NAME were ineffective in preventing the inhibiting effect of EGCg. The effect of MB suggests that, in part, spontaneous motility inhibition is induced by the activation of guanylate cyclase, while adenylate cyclase is not involved in this action. The precise mechanism of this effect remains to be investigated. The present study shows that EGCg effects (myenteric neuron depolarization) observed at the cellular level at concentrations in the range of 10 −6 M (6, 7) do not induce significant effects at the tissue level. It is possible that in the experimental design of the present study, local concentrations were smaller than the general concentration in the chamber. However, the lack of the TTX effect suggests the direct action of EGCg on intestinal smooth muscle. It was reported that catechins directly activate superoxide dismutase in the rat brain (19) . Moreover, catechins inhibit xanthine oxidase in liver (20) . Thus, it is possible that EGCg induces a non-selective effect on intracellular functions that results in the inhibition of spontaneous motility in the intestine. 
